SS
Subhash Sopanrao Suryawanshi
About Subhash Sopanrao Suryawanshi
Data last updated:
Subhash Sopanrao Suryawanshi is a Director at Ardent Life Sciences Private Limited (since 2014), Director at Ardentlife Pharmaceutical Private Limited (since 2024) and Director at Ardentlifecare Formulation Private Limited (since 2024), and holds 2 more current directorships. The companies operate in Pharma and Paper. The largest current company by reported revenue is Ardent Life Sciences Private Limited at ₹13.53 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Sep 2014 | 2014 | ₹13.53 Cr (FY 2024) | Active | |
| Director | 05 Jul 2024 | 2024 | Active | ||
| Director | 24 Apr 2024 | 2024 | Active | ||
| Designated Partner | 23 Mar 2017 | 2017 | Active | ||
| Designated Partner | 04 Jan 2016 | 2016 | Active |
Board colleagues of Subhash Sopanrao Suryawanshi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sheetal Subhash Suryawanshi | 08685147 | Ardent Life Sciences Private Limited , Ardentlifecare Formulation Private Limited | Nominee |
| Supriya Baran Chanda | 08308282 | Ardentlife Pharmaceutical Private Limited | Additional Director |
| Vijay Singh Patel | 10696555 | Ardentlife Pharmaceutical Private Limited | Director |
| Nanasaheb Prabhakarrao Dhavan | 08319595 | Arki Pharmaceuticals Llp | Designated Partner |
| Deepti Rajeev Bhasin | 09583626 | Carrel Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Subhash Sopanrao Suryawanshi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Subhash Sopanrao Suryawanshi
Subhash Sopanrao Suryawanshi currently holds 5 directorships: Ardent Life Sciences Private Limited (Director, since 01 Sep 2014, revenue ₹13.53 Cr (FY 2024)); Ardentlife Pharmaceutical Private Limited (Director, since 05 Jul 2024); Ardentlifecare Formulation Private Limited (Director, since 24 Apr 2024); Arki Pharmaceuticals Llp (Designated Partner, since 23 Mar 2017); Carrel Pharmaceuticals Llp (Designated Partner, since 04 Jan 2016).
Subhash Sopanrao Suryawanshi was first appointed on 01 Sep 2014 as Director at Ardent Life Sciences Private Limited. The most recent appointment on record is 05 Jul 2024 at Ardentlife Pharmaceutical Private Limited.
The current boards of Subhash Sopanrao Suryawanshi's companies include Sheetal Subhash Suryawanshi (Ardent Life Sciences Private Limited), Supriya Baran Chanda (Ardentlife Pharmaceutical Private Limited), Vijay Singh Patel (Ardentlife Pharmaceutical Private Limited), Nanasaheb Prabhakarrao Dhavan (Arki Pharmaceuticals Llp), Deepti Rajeev Bhasin (Carrel Pharmaceuticals Llp).